compounded semaglutide crackdown news november 2025 Ozempic Knockoffs Survive Thanks to Loophole Drug compounders sue FDA over

GLP-1 medicines in neuro- and cardiovascular inflammation Microglia secrete pro-inflammatory cytokines upon activation, stimulating nearby reactive astrocytes and amplifying local neuroinflammation

Every vial also includes two QR codes

Retatrutide is currently in Phase 3 clinical trials with FDA approval expected in 2025-2026

2026 Semaglutide Cost by Channel The short answer

Compounded semaglutide is not FDA-approved and may only be prescribed when a licensed provider determines that a compounded preparation is clinically appropriate for an individual patient

Structured follow-up so side effects can be reviewed and dose changes made appropriately